FDA Approves Tecelra for Metastatic Synovial Sarcoma
Paula Cannon, PhD | August 06, 2024
As we celebrate this milestone, we must continue refining our approaches, ensuring safety, and exploring new frontiers. Tecelra and the success of other approved therapeutics should inspire us to aim even higher.
Cell & Gene Therapy Approval | President's Message
Read Full Story